INTRODUCTION {#s1}
============

Diabetes is a chronic metabolic disease with increasing prevalence worldwide nowadays owing to the lifestyle modifications and increasing life expectancy \[[@R1]\]. According to the International Diabetes Federation, 415 million adults have diabetes and this figure is expected to rise to 642 million by 2040 \[[@R2]\]. As high blood glucose levels can damage blood vessels, nerves, eyes and kidneys, patients with diabetes may suffer from a number of serious complications. Depression is a common psychiatric mood disorder with increasing prevalence and is one of the largest single causes of disability around the world \[[@R3]\].

Diabetes and depression carry a large public health burden presently and also a heavy burden on health budgets in the future. In recent years, accumulating studies indicate the close associations between the two chronic diseases, diabetes and depression \[[@R4]--[@R7]\]. It is found that comorbid diabetes and depression is common, which results in significant detrimental impact on health outcomes, including a significantly increased risk of mortality and increased healthcare cost \[[@R8]\]. Although there is a high rate of comorbid depression in patients with diabetes, it is unrecognized and untreated largely \[[@R9], [@R10]\]. Moreover, the prevalence of diabetes and depression differs in men and women. Women are about twice as likely as men to develop depression, while the prevalence of diabetes is higher in men than women \[[@R11], [@R12]\]. Thus, the present study aimed to perform a bidirectional random effects meta-analysis to quantitatively assess the strength of the relationships between diabetes and depression, and to examine the difference of the strength in males and females, to provide implications for future interventional studies of the two diseases.

RESULTS {#s2}
=======

Risk of diabetes in patients with depression {#s2_1}
--------------------------------------------

Selection process of studies included in the present study was shown in Figure [1](#F1){ref-type="fig"}. There were 32 eligible studies covering 1274337 subjects included in the assessment of risk of diabetes in patients with depression. Table [1](#T1){ref-type="table"} showed the first author, year of publication, country, number of subjects, the odds ratio (OR) and the corresponding 95% confidence intervals (CI), extracted from each study. The meta-analytic results were shown in Figure [2](#F2){ref-type="fig"}, which indicated that depression patients were at higher risk of developing diabetes (OR = 1.34, 95%CI = \[1.23, 1.46\]). Statistically moderate heterogeneity was found among these studies (*p* = 0.000, *I^2^* = 68.4%).

![Selection of studies for inclusion in the meta-analysis](oncotarget-08-23389-g001){#F1}

###### Characteristics of the studies included in the analysis of risk of diabetes in patients with depression

  References                      Country       Subjects   Age         Weight (%)   OR     95% CI
  ------------------------------- ------------- ---------- ----------- ------------ ------ -----------
  Deschênes 2016 \[[@R13]\]       Canada        2486       40-69       0.17         1.61   0.44-5.87
  Freitas 2016 \[[@R14]\]         England       4454       50+         1.10         1.29   0.63-2.64
  Khambaty 2016 \[[@R15]\]        US            2156       60+         5.05         1.18   0.95-1.46
  Koyanagi 2016 \[[@R16]\]        Spain         201 337    18+         3.63         1.57   1.21-2.03
  Chen 2013 \[[@R17]\]            China         11694      60.1±13.2   5.25         2.02   1.80-2.27
  Bhowmik 2012 \[[@R18]\]         Bangladesh    2293       20+         0.65         3.52   2.42-5.12
  Chien 2012 \[[@R19]\]           China         766427     18+         6.04         1.53   1.39-1.69
  Nichols 2011 \[[@R20]\]         US            58056      50+         6.46         1.10   1.02-1.20
  Karakus 2011 \[[@R21]\]         US            12652      51-61       2.30         1.50   1.01-2.24
  Pan 2010 \[[@R22]\]             US            65381      50-75       6.23         1.17   1.05-1.30
  Demakakos 2010 \[[@R23]\]       UK            6111       50+         2.54         1.62   1.15-2.29
  Atlantis 2010 \[[@R24]\]        Australia     1000       65+         0.61         2.29   1.28-4.10
  Campayo 2010 \[[@R25]\]         Spain         3521       55+         1.52         1.65   1.02-2.66
  Golden 2008 \[[@R26]\]          US            5201       45-84       3.71         1.21   0.87-1.67
  Eriksson 2008 \[[@R27]\]        Sweden        2127       35+         0.37         1.60   0.60-4.30
  Eriksson 2008 \[[@R27]\]        Sweden        3100       35+         2.14         0.70   0.30-1.60
  Engum 2007 \[[@R28]\]           Norway        37291      30-89       4.91         1.51   1.27-1.81
  Engum 2007 \[[@R28]\]           Norway        37291      30-89       2.25         1.17   0.70-1.95
  Carnethon 2007 \[[@R29]\]       US            4681       65+         2.33         1.57   1.07-2.29
  Brown 2005 \[[@R30]\]           Canada        92677      20-50       6.16         1.23   1.10-1.37
  Maty 2005 \[[@R31]\]            US            6147       17-94       4.24         1.08   0.79-1.47
  Mallon 2005 \[[@R32]\]          Sweden        550        45-65       0.48         1.30   0.40-3.60
  Mallon 2005 \[[@R32]\]          Sweden        620        45-65       0.70         0.90   0.30-2.90
  Everson-Rose 2004 \[[@R33]\]    US            2662       42-52       1.81         1.46   0.90-2.36
  van den Akker 2004 \[[@R34]\]   Netherlands   68004      20-50       5.49         0.98   0.79-1.21
  Palinkas 2004 \[[@R35]\]        US            971        50-89       0.39         2.50   1.29-4.87
  Kumari 2004 \[[@R36]\]          UK            5807       35-55       3.31         1.17   0.80-1.70
  Kumari 2004 \[[@R36]\]          UK            2579       35-55       2.38         1.03   0.60-1.80
  Golden 2004 \[[@R37]\]          US            11615      45-64       4.61         1.31   1.04-1.64
  Arroyo 2004 \[[@R38]\]          US            72178      45-72       5.10         1.22   1.00-1.50
  Carnethon 2003 \[[@R39]\]       US            6190       25-74       1.85         1.86   1.27-2.71
  Saydah 2002 \[[@R40]\]          US            8870       32-86       3.84         1.11   0.79-1.56
  Stellato 2000 \[[@R41]\]        US            1156       40-70       0.15         3.09   1.34-7.12
  Kawakami 1999 \[[@R42]\]        Japan         2380       18-53       0.31         2.32   1.06-5.08
  Eaton 1996 \[[@R43]\]           US            1715       18+         0.24         2.23   0.90-5.55
  Palinkas 1991 \[[@R44]\]        US            1585       50+         1.69         1.34   0.78-2.31
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Risk of diabetes in male patients with depression {#s2_2}
-------------------------------------------------

Effects of gender on the strength of the bidirectional relationships between diabetes and depression were examined through further gender-subgroup analysis. A total of 10 studies were included in the male subgroup analysis. Table [2](#T2){ref-type="table"} listed the main characteristics about the number of male subjects, OR and the corresponding 95% CI of each study. According to the meta-analytic results shown in Figure [3](#F3){ref-type="fig"}, depression patients were at 63% increased risk for developing diabetes (OR = 1.63, 95%CI = \[1.48, 1.78\]) than non-depressive male subjects, and heterogeneity was not found among these studies (*p* = 0.446, *I^2^* = 0.0%).

###### Characteristics of the studies included in the male subgroup analysis of risk of diabetes in patients with depression

  References                      Country       Subjects   Males %   Age         Weight (%)   OR     95% CI
  ------------------------------- ------------- ---------- --------- ----------- ------------ ------ -----------
  Chen 2013 \[[@R17]\]            China         11694      40.3      60.1±13.2   26.01        1.83   1.56-2.16
  Chien 2012 \[[@R19]\]           China         766427     48.8      18+         34.63        1.72   1.48-2.00
  Eriksson 2008 \[[@R27]\]        Sweden        5227       40.7      35+         0.68         1.60   0.60-4.30
  Engum 2007 \[[@R28]\]           Norway        37291      47.2      30-89       17.57        1.42   1.11-1.84
  Engum 2007 \[[@R28]\]           Norway        37291      47.2      30-89       2.49         1.26   0.62-2.56
  Mallon 2005 \[[@R32]\]          Sweden        1170       47        45-65       0.91         1.30   0.40-3.60
  van den Akker 2004 \[[@R34]\]   Netherlands   68004      48.8      20-50       4.71         1.78   1.21-2.62
  Kumari 2004 \[[@R36]\]          US            8386       69.2      35-55       11.56        1.17   0.80-1.70
  Stellato 2000 \[[@R41]\]        US            1156       100       40-70       0.28         3.09   1.34-7.12
  Kawakami 1999 \[[@R42]\]        Japan         2380       100       18-53       0.58         2.32   1.06-5.08
  Palinkas 1991 \[[@R44]\]        US            1585       46.7      50+         0.57         2.04   0.85-4.90
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Risk of diabetes in female patients with depression {#s2_3}
---------------------------------------------------

There were 11 eligible studies included in the female subgroup analysis. Table [3](#T3){ref-type="table"} showed the extracted information of each eligible study. The pooled OR indicated that depression patients were at higher risk for diabetes (OR = 1.29, 95%CI = \[1.07, 1.51\], Figure [4](#F4){ref-type="fig"}) than non-depressive female subjects and statistically moderate heterogeneity was found among these studies (*p* = 0.000, *I^2^* = 75.3%).

###### Characteristics of the studies included in the female subgroup analysis of risk of diabetes in patients with depression

  References                      Country       Subjects   Females %   Age         Weight (%)   OR     95% CI
  ------------------------------- ------------- ---------- ----------- ----------- ------------ ------ -----------
  Chen 2013 \[[@R17]\]            China         11694      59.7        60.1±13.2   10.41        2.23   1.89-2.62
  Chien 2012 \[[@R19]\]           China         766427     51.2        18+         13.33        1.44   1.27-1.63
  Pan 2010 \[[@R22]\]             US            65381      100         50-75       13.99        1.17   1.05-1.30
  Eriksson 2008 \[[@R27]\]        Sweden        5227       59.3        35+         6.39         0.70   0.30-1.60
  Engum 2007 \[[@R28]\]           Norway        37291      52.8        30-89       9.84         1.59   1.24-2.04
  Engum 2007 \[[@R28]\]           Norway        37291      52.8        30-89       4.38         1.09   0.52-2.27
  Mallon 2005 \[[@R32]\]          Sweden        1170       53          45-65       2.37         0.90   0.30-2.90
  Everson-Rose 2004 \[[@R33]\]    US            2662       100         42-52       5.57         1.46   0.90-2.36
  van den Akker 2004 \[[@R34]\]   Netherlands   68004      51.2        20-50       10.08        0.82   0.52-1.29
  Kumari 2004 \[[@R36]\]          US            8386       30.8        35-55       6.97         1.03   0.60-1.80
  Arroyo 2004 \[[@R38]\]          US            72178      100         45-72       12.30        1.22   1.00-1.50
  Palinkas 1991 \[[@R44]\]        US            1585       53.3        50+         4.38         1.13   0.55-2.30
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Risk of depression in patients with diabetes {#s2_4}
--------------------------------------------

For the direction of diabetes leading to depression, there were a total of 24 eligible studies covering 329658 subjects. Table [4](#T4){ref-type="table"} collected the extracted main characteristics, including the first author, year of publication, country, and number of subjects, OR and the corresponding 95% CI of each included study. The pooled results were shown in Figure [5](#F5){ref-type="fig"}, which indicated that patients with diabetes were at higher risk for developing depression (OR = 1.28, 95%CI = \[1.15, 1.42\]) than non-diabetic subjects with statistically significant heterogeneity among these studies (*p* = 0.000, *I^2^* = 62.5%).

###### Characteristics of the studies included in the analysis of risk of depression in patients with diabetes

  References                   Country        Subjects   Age         Weight (%)   OR     95% CI
  ---------------------------- -------------- ---------- ----------- ------------ ------ ------------
  van Dooren 2016 \[[@R45]\]   Netherlands    862        40-75       0.26         3.15   1.49-6.67
  Westra 2016 \[[@R46]\]       Netherlands    527        60-87       0.66         1.96   0.94-4.10
  Meurs 2015 \[[@R47]\]        Netherlands    90686      18-93       6.41         1.39   1.10-1.76
  Deschênes 2015 \[[@R48]\]    Canada         17623      15+         6.89         1.18   0.92-1.52
  Bruce 2015 \[[@R49]\]        Australia      184        70.2±10.1   0.16         2.77   1.00-7.70
  Islam 2015 \[[@R50]\]        Australia      1182       50.4±11.4   0.09         6.40   3.40-12.30
  Chen 2013 \[[@R17]\]         China          33914      60.1±13.2   6.81         1.43   1.16-1.77
  Hamer 2011 \[[@R51]\]        UK             4338       62.9±9      3.04         1.52   1.01-2.30
  Pan 2010 \[[@R22]\]          US             7415       50-75       9.88         1.29   1.18-1.40
  O\'Connor 2009 \[[@R52]\]    US             17076      40+         6.81         1.46   1.19-1.80
  Almawi 2008 \[[@R53]\]       Bahrain        275        31-60       0.09         3.82   1.43-10.25
  Golden 2008 \[[@R26]\]       US             5201       45-84       4.09         1.52   1.09-2.12
  Luijendijk 2008 \[[@R54]\]   Netherlands    2931       61+         0.87         2.07   1.11-3.85
  Maraldi 2007 \[[@R55]\]      Italy          2522       70-79       7.38         1.31   1.07-1.61
  Engum 2007 \[[@R28]\]        Norway         37291      30-89       3.36         1.24   0.78-1.98
  Engum 2007 \[[@R28]\]        Norway         37291      30-89       0.97         1.56   0.73-3.31
  Kim 2006 \[[@R56]\]          South Korean   521        65+         1.39         1.00   0.40-2.50
  de Jonge 2006 \[[@R57]\]     Spain          4803       55+         5.75         1.41   1.08-1.83
  Brown 2006 \[[@R58]\]        Canada         88776      20-95       9.94         1.04   0.94-1.15
  Polsky 2005 \[[@R59]\]       US             8387       51-61       8.30         1.17   0.98-1.41
  Palinkas 2004 \[[@R35]\]     US             971        50-89       4.85         0.73   0.41-1.30
  Bisschop 2004 \[[@R60]\]     Netherlands    1839       55-85       7.96         0.73   0.53-1.00
  Rajala 1997 \[[@R61]\]       Finland        734        55          0.83         2.10   1.20-4.00
  Wing 1990 \[[@R62]\]         US             64         30-70       2.84         1.96   0.70-2.05
  Weyerer 1989 \[[@R63]\]      Hungary        1536       15+         0.39         3.15   1.69-5.87
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Publication bias {#s2_5}
----------------

Funnel plot and Egger\'s test were employed to estimate the publication bias among the included studies. The funnel plot showed generally symmetrical distribution, suggesting no evidence of publication bias for the outcomes in both directions. Egger\'s test also found low possibility of publication bias (*p* = 0.262 for the direction of depression leading to diabetes and *p* = 0.326 for the direction of diabetes leading to depression).

DISCUSSION {#s3}
==========

Diabetes and depression are two highly prevalent chronic diseases around the world, and increasing evidence indicates the high rates of co-occurrence of the two diseases. The present study was designed to conduct a quantitative assessment on the bidirectional relationships between the two diseases to provide directions for their prevention and treatment. It was found that there was a 34% increased risk of developing diabetes in depression patients than non-depressive subjects, and a 28% increased risk of developing depression in patients with diabetes compared with non-diabetic subjects. Thus, the study provides evidence that the relationships between diabetes and depression are bidirectional with similar strengths in both directions.

The mechanisms accounting for the relationships between diabetes and depression should be multiple in terms of biological, psychological and socioeconomic determinants \[[@R64]--[@R66]\]. First, depression can be regarded as an additional risk factor for diabetes. Depression patients are less likely to be compliant with dietary and weight loss recommendations and are more prone to be lack of physical exercise, which can lead to worsening of obesity and insulin resistance, and thus may increase the risk of developing diabetes. Some drugs used to treat depression may lead to weight gain and obesity, which could make individuals susceptible to the development of diabetes \[[@R67], [@R68]\]. Second, diabetes can also increase the risk of depression. For patients with diabetes, poor control of blood sugar, strict diet and physical exercise requirements, and treatment may increase the incidence of depression. It was found that chronic stress could cause hyper-activation of the hypothalamic-pituitary-adrenal axis and an increase in cortical, which has been proposed to be an important pathway to interpret the clinical relationships between diabetes and depression \[[@R69]--[@R71]\]. In addition, on the basis of the large-scale genome wide association studies about type 2 diabetes and major depressive disorder, we performed a bioinformatics analysis on the genetic overlap between the two diseases \[[@R72]\]. The overlapped single nucleotide polymorphisms and functional enrichment pathway of the annotated genes were identified, which provided clues for future treatment strategies for the two diseases \[[@R72]\].

Our analysis has several limitations. First, we analyzed the effect of gender on the risk of diabetes in patients with depression, while the current available data cannot permit us to perform the gender subgroup analysis for the direction of diabetes leading to depression. Second, as many studies did not specify the type of diabetes, we analyzed the overall relationships of diabetes with depression. Third, several case-control and cross-sectional studies were employed in the bidirectional analysis and thus we cannot exclude the recall and selection bias.

MATERIALS AND METHODS {#s4}
=====================

Search strategy and selection criteria {#s4_1}
--------------------------------------

With the combination of the following terms "depression" or "depressive" and "diabetes", the Medline and PsycINFO databases were scanned for articles written in English and published in peer-reviewed journals up to October 2016. The conference proceedings and reference lists from retrieved articles were also screened to obtain additional relevant reports. Cohort, cross-sectional and case-control studies providing OR and 95%CI, or enough data to calculate the two parameters, of risk of developing diabetes in patients with depression or vice versa, were eligible for inclusion. Two investigators (QSZ and LS) independently screened the literature and extracted information from the eligible studies. Any disagreement was resolved by consensus. The flow chart in Figure [1](#F1){ref-type="fig"} summarized the references selection process. In total, 51 studies were finally included in the bidirectional analysis \[[@R13]--[@R63]\], among which, 32 studies were about the risk of diabetes in patients with depression, and 24 studies were about the risk of depression in patients with diabetes.

Meta-analytic methods {#s4_2}
---------------------

The meta-analysis was performed for the extracted fully adjusted ORs employing the Stata statistical software version 12.0 (Stata Corp LP, College Station, Texas) with the random effects model. To assess the effect of gender on the relationships between diabetes and depression, the gender-subgroup analysis was further performed. Heterogeneity was evaluated employing Q-test and *I^2^* score. Funnel plot and Egger\'s test were used to examine the publication bias among the included studies.

CONCLUSIONS {#s5}
===========

In summary, the present quantitative assessmentprovides evidence that the relationships between diabetes and depression are bidirectional with similar strengths in both directions, which implies that physicians should be aware of the co-occurrence of depression and diabetes.
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